Tag: Biotechnology

Impact Newswire brings you the latest in Biotechnology news.

IDRx
Untied Kingdom

GSK Enters Agreement to Acquire IDRx, Inc.

Press Release – January 13, 2025 – PLYMOUTH, Mass. – GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based, clinical-stage biopharmaceutical company dedicated to developing precision therapeutics for the treatment of GIST. Under the agreement, GSK will pay $1 billion upfront, with potential for an additional $150 million success-based … Continue reading GSK Enters Agreement to Acquire IDRx, Inc.

Impact Newswire
BIOTECANADA
Global

BIOTECanada Welcomes New President & CEO

Press Release – January 10, 2025 – OTTAWA, Ontario – On behalf of the Board of Directors of BIOTECanada, Chairman Oliver Technow is pleased to announce the appointment of Wendy Zatylny as the incoming President & CEO of BIOTECanada, representing the biotechnology ecosystem in Canada. “Her experience in leading a national industry association equips her with valuable insights and expertise that will drive BIOTECanada’s ongoing … Continue reading BIOTECanada Welcomes New President & CEO

Impact Newswire
Enveda
United States

Enveda Welcomes Jason Kim as Chief Financial Officer

Press Release – January 10, 2025 – BOULDER, Colo. – Enveda, a biotechnology company using AI to translate life’s chemistry into new medicines, today announced the appointment of Jason Kim as Chief Financial Officer (CFO). Mr. Kim brings more than 20 years of biopharmaceutical corporate development and financial leadership experience to the Enveda team. “His proven track record of driving financial and operational success in … Continue reading Enveda Welcomes Jason Kim as Chief Financial Officer

Impact Newswire
Aro Biotherapeutics
United States

Aro Biotherapeutics Appoints Glenn Crater, MD, as Chief Medical Officer

Press Release – January 07, 2025 – PHILADELPHIA – Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent, tissue-targeted medicines, today announced the appointment of Glenn D. Crater, MD, as chief medical officer (CMO). Dr. Crater will lead the development of Aro’s pipeline of Centyrin-based, tissue-targeted medications, including the company’s lead product candidate ABX1100, a novel potential treatment for Pompe disease. “In addition, I … Continue reading Aro Biotherapeutics Appoints Glenn Crater, MD, as Chief Medical Officer

Impact Newswire
Tango Biosciences
United States

Michael Scholle Appointed CEO of Tango Biosciences

Co-founder Brian Kay to assume Chief Scientific Officer, focused on scientific innovation and operations Press Release – January 07, 2025 – CHICAGO – Tango Biosciences, Inc., the premier research partner for custom affinity reagents by phage display, announced Michael Scholle, MS, MBA as Chief Executive Officer effective immediately. Scholle is one of three co-founders of Tango Biosciences and an active board member. This transition enables president and … Continue reading Michael Scholle Appointed CEO of Tango Biosciences

Impact Newswire
City Therapeutics, Inc.
United States

City Therapeutics Appoints Andy Orth as Chief Executive Officer

Orth brings more than 25 years of global industry experience to CEO role, with strong track record in corporate and commercial strategy City co-founder Dr. John Maraganore to retain active executive chair role to ensure company leads next-generation RNAi therapeutics CAMBRIDGE, Mass – City Therapeutics, Inc., a biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, today announced the appointment of Andrew “Andy” Orth … Continue reading City Therapeutics Appoints Andy Orth as Chief Executive Officer

Impact Newswire
Maurice van Tilburg
Europe

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

Current Renovaro Chairman to Lead Subsidiary’s Development Program and Commercialization Los Angeles and Amsterdam – December 30, 2024 – Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announced Chairman of the Board, Maurice van Tilburg, has been appointed as Chief Executive Officer of its subsidiary GEDi Cube BV (a leader in AI-driven cancer diagnostics by integrating multi-omics with liquid biopsies) DBA RenovaroCube. … Continue reading Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

Impact Newswire
Cure Rare Disease
United States

Cure Rare Disease Appoints Brittany Stineman as Chief Advancement Officer

Press Release – December 18, 2024 – WOODBRIDGE, Conn. – Cure Rare Disease, a nonprofit biotechnology organization dedicated to advancing treatments for neglected rare and genetic diseases, is proud to announce Brittany Stineman as its new Chief Advancement Officer, effective January 2025. “Brittany’s story is a testament to the power of hope, resilience, and action” Post this As a mother who faced the unimaginable journey … Continue reading Cure Rare Disease Appoints Brittany Stineman as Chief Advancement Officer

Impact Newswire